Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

<p>Overall survival of ATM, BRCA2 mutant, and HRDother mPCs.</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Justin Hwang (15925675) (author)
Andere auteurs:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
door: Justin Hwang (15925675)
Gepubliceerd in: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
door: Justin Hwang (15925675)
Gepubliceerd in: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
door: Justin Hwang (15925675)
Gepubliceerd in: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
door: Justin Hwang (15925675)
Gepubliceerd in: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
door: Justin Hwang (15925675)
Gepubliceerd in: (2025)

Structural variants of <i>Fragaria vesca</i>
door: Minto Odagiri (22680003)
Gepubliceerd in: (2025)

Gene expression data of <i>Fragaria vesca</i>
door: Minto Odagiri (22680003)
Gepubliceerd in: (2025)

Processed snRNA-seq data from wild-type and <i>Pink1</i>-deficient mouse gut
door: Muhammad Junaid (14524523)
Gepubliceerd in: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
door: Jiwei Bai (15051797)
Gepubliceerd in: (2025)

liverRegression code.
door: Amy Stephen (22684448)
Gepubliceerd in: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
door: Félix Blanc-Durand (15049400)
Gepubliceerd in: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
door: Nicholas Mikolajewicz (11242755)
Gepubliceerd in: (2025)

Data file 1. Figure 1. Overview of <i>L. loa</i> specimen and genomic representation
door: Jeanne Arline Rajaonarivelo (17282572)
Gepubliceerd in: (2025)

<b>Demographic History and </b><b>Natural Selection</b><b> Regimes Shape Divergent Genomic Architectures in Two Endangered Island Oaks</b>
door: Wenji Luo (4760160)
Gepubliceerd in: (2025)

<i>K. pneumoniae</i> genomes represented in amr.watch as of 31 March 2025, filtered by the presence of the carbapenem resistance gene, <i>bla</i><sub>NDM-5</sub>.
door: Sophia David (4172902)
Gepubliceerd in: (2025)

<b>Evolution of extensive neo-sex chromosomes and PAR shift in </b><b><i>Agapornis</i></b><b> lovebirds (</b><b>Supporting files, FISH raw data)</b>
door: Haoran Luo (16515177)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
door: Eileen M. Boyle (15015425)
Gepubliceerd in: (2025)

The interactive amr.watch application here shows an overview from 179,518 <i>E. coli</i> genomes available as of 31 March 2025.
door: Sophia David (4172902)
Gepubliceerd in: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
door: Lenka Stolarova (16547259)
Gepubliceerd in: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
door: Lenka Stolarova (16547259)
Gepubliceerd in: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
door: Lenka Stolarova (16547259)
Gepubliceerd in: (2025)

DeepEvo
door: Juntian Qi (22578974)
Gepubliceerd in: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
door: Elena Llano (14963220)
Gepubliceerd in: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
door: Elena Llano (14963220)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1uv6jsaaiadvtmelfkvtl1413f